Symbiotec Pharmalab Raises Rs 526 Crore from Anchor Investors Ahead of Rs 1,757 Crore IPO
Symbiotec Pharmalab is launching its initial public offering (IPO) from August 24 to 27, aiming to raise Rs 1,757 crore at a price band of Rs 938-988 per share. The IPO includes a fresh issue of Rs 150 crore and an offer for sale of Rs 1,607 crore by promoters and investors. The company raised Rs 526 crore from 34 anchor investors, including mutual funds, insurance companies, and foreign portfolio investors. Proceeds from the fresh issue will be used for debt repayment and general corporate purposes.
First-hand measurement across 5 sources
We measured how 5 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (51/100). Lens Score 55/100.
Outlets measured: businessstandard, economictimes, moneycontrol, news18, mint. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
mint broke this story on 21 Aug, 02:17 pm. Other outlets followed.